Stockscreener 앱 받기
39.11
0.67%
0.26
Sionna Therapeutics Inc 주식(SION)의 최신 뉴스
Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares - AOL.com
Sionna Therapeutics (NASDAQ:SION) Stock Price Up 8.1%Here's Why - MarketBeat
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target - TipRanks
BTIG Research Reiterates Buy Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeat
SION: Advancing NBD1 stabilizers to transform CF care, with key data expected mid-2026 - TradingView — Track All Markets
SION: First-in-class NBD1 stabilizers target full CFTR correction, with pivotal data expected mid-2026 - TradingView — Track All Markets
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 10.1%Here's What Happened - MarketBeat
Assessing Sionna Therapeutics (SION) Valuation After Recent Share Price Swings And Premium P/B Multiple - Yahoo Finance
Sionna Therapeutics Advances Cystic Fibrosis Treatment with New Study - MSN
Sionna Therapeutics, Inc. (SION) Stock Analysis: A 27.73% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Assessing Sionna Therapeutics (SION) Valuation After A Sharp Share Price Move And Elevated Price To Book Ratio - Sahm
Market Recap: How Sionna Therapeutics Inc. stock compares to industry benchmarks2025 Sector Review & Trade Opportunity Analysis - Улправда
Is Sionna Therapeutics Inc. stock positioned for long term growthPortfolio Value Summary & Smart Money Movement Tracker - Улправда
Sionna Therapeutics (NASDAQ:SION) Trading Up 7.7%Here's Why - MarketBeat
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sionna Therapeutics (NASDAQ:SION) Shares Down 7.5%What's Next? - MarketBeat
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Orbimed Advisors LLC Reduces Stake in Sionna Therapeutics Inc - GuruFocus
Raymond James raises Sionna Therapeutics stock price target on CF drug potential - Investing.com Canada
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million - AOL.com
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million - The Motley Fool
Sionna Therapeutics Insider Sold Shares Worth $1,486,010, According to a Recent SEC Filing - marketscreener.com
OrbiMed Advisors sells Sionna Therapeutics [SION] shares for $1.48m By Investing.com - Investing.com Australia
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 33,356 Shares of Stock - MarketBeat
OrbiMed Advisors sells Sionna Therapeutics [SION] shares for $1.48m - Investing.com
Sionna Therapeutics (NASDAQ:SION) Sets New 12-Month HighWhat's Next? - MarketBeat
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis - TipRanks
FY2025 Earnings Estimate for SION Issued By Lifesci Capital - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Now Covered by Analysts at Lifesci Capital - Defense World
LifeSci Capital Initiates Coverage of Sionna Therapeutics (SION) with Outperform Recommendation - Nasdaq
Sionna Therapeutics (NASDAQ:SION) Coverage Initiated by Analysts at Lifesci Capital - MarketBeat
LifeSci Capital Initiates Coverage on Sionna Therapeutics With Outperform Rating, $60 Price Target - marketscreener.com
Sionna Therapeutics (NASDAQ:SION) Director Sells $40,050.00 in Stock - Defense World
Sionna Therapeutics, Inc.(NasdaqGM:SION) added to S&P Biotechnology Select Industry Index - marketscreener.com
Sionna Therapeutics, Inc.(NasdaqGM: SION) added to NASDAQ Biotechnology Index - marketscreener.com
Sionna Therapeutics (NASDAQ:SION) Reaches New 1-Year High – Still a Buy? - Defense World
Peter Thompson Sells 900 Shares of Sionna Therapeutics (NASDAQ:SION) Stock - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Director Sells $38,928.75 in Stock - MarketBeat
Shareholder OrbiMed Advisors LLC Sells 1,875 ($83.4K) Of Sionna Therapeutics Inc [SION] - TradingView — Track All Markets
Sionna Therapeutics (NASDAQ:SION) Sets New 1-Year HighHere's What Happened - MarketBeat
Peter Thompson Sells 875 Shares of Sionna Therapeutics (NASDAQ:SION) Stock - MarketBeat
How Sionna Therapeutics Inc. stock reacts to oil pricesTrade Entry Summary & Short-Term Trading Alerts - Улправда
Sionna Therapeutics, Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Sionna Therapeutics, Inc. Rings the Closing Bell - Nasdaq
Braidwell LP Invests $18.77 Million in Sionna Therapeutics, Inc. $SION - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Upgraded at Wall Street Zen - MarketBeat
Sionna Therapeutics (SION) Stock Analysis Report | Financials & Insights - Benzinga
Sionna Therapeutics chief legal officer sells $415,330 in stock By Investing.com - Investing.com Canada
Sionna Therapeutics chief legal officer sells $415,330 in stock - Investing.com India
4.73%
0.92%
자본화:
|
볼륨(24시간):